Document is current

Any future updates will be listed below

Health-related quality-of-life outcomes with regorafenib in advanced gastric and esophagogastric junction cancer: results from the INTEGRATE trials

Crossref DOI link: https://doi.org/10.1007/s10120-025-01670-2

Published Online: 2025-10-10

Published Print: 2025-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark